RRM2B and cancer: We found that the mRNA expression levels of RRM1, RRM2, and RRM2B ranked in the top 10% of the up-regulated DEGs in 24.0% (86 of 358), 38.3% (136 of 355), and 10.5% (22 of 209) of the identified cancer studies, respectively.